ストックスクリーナーアプリを入手
75.58
0.33%
0.2254
前日終値:
$75.35
開ける：
$75.87
24時間の取引高:
1.06M
Relative Volume:
0.67
時価総額：
$36.85B
収益：
$10.40B
当期純損益:
$980.00M
株価収益率:
38.27
EPS:
1.9749
ネットキャッシュフロー:
$1.61B
1週間 パフォーマンス:
+0.45%
1か月 パフォーマンス:
-13.29%
6か月 パフォーマンス:
+0.65%
1年 パフォーマンス:
-18.45%
1日の値動き範囲:
$74.88
$75.98
1週間の範囲:
$73.21
$76.35
52週間の値動き範囲:
$71.55
$99.20
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
75.60 | 36.73B | 10.40B | 980.00M | 1.61B | 1.9749 |
ISRG
Intuitive Surgical Inc
|
466.39 | 163.73B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.76 | 44.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
44.02 | 36.12B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
223.38 | 32.70B | 5.40B | 1.49B | 1.78B | 10.12 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-26 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | 開始されました | William Blair | Mkt Perform |
| 2026-01-20 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-09 | ダウングレード | Stifel | Buy → Hold |
| 2025-12-11 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-08-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2025-05-20 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 繰り返されました | BTIG Research | Buy |
| 2025-03-28 | 繰り返されました | Needham | Buy |
| 2025-03-25 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-01-24 | 繰り返されました | Needham | Buy |
| 2025-01-10 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 繰り返されました | Needham | Buy |
| 2024-11-12 | 繰り返されました | Needham | Buy |
| 2024-10-10 | アップグレード | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | アップグレード | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 開始されました | Goldman | Buy |
| 2024-03-14 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 開始されました | Bernstein | Outperform |
| 2023-12-18 | ダウングレード | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-05-10 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | アップグレード | Societe Generale | Sell → Hold |
| 2022-12-22 | 開始されました | Mizuho | Buy |
| 2022-11-17 | ダウングレード | Societe Generale | Hold → Sell |
| 2022-08-11 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-05-13 | 再開されました | Credit Suisse | Outperform |
| 2022-05-12 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-11 | 開始されました | BofA Securities | Buy |
| 2022-01-18 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 開始されました | Oppenheimer | Perform |
| 2021-07-14 | 開始されました | Deutsche Bank | Buy |
| 2021-05-06 | アップグレード | Citigroup | Sell → Neutral |
| 2021-03-22 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-11-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-07-06 | ダウングレード | Citigroup | Neutral → Sell |
| 2020-07-06 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-04-08 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Argus | Hold → Buy |
| 2020-03-24 | アップグレード | Societe Generale | Sell → Hold |
| 2020-03-13 | アップグレード | UBS | Neutral → Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-26 | アップグレード | Berenberg | Hold → Buy |
| 2020-01-08 | 開始されました | Argus | Hold |
| 2019-10-29 | 開始されました | Stephens | Equal-Weight |
| 2019-08-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-06-24 | 開始されました | SVB Leerink | Mkt Perform |
| 2019-06-14 | 開始されました | BTIG Research | Neutral |
| 2019-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
すべてを表示
Alcon Inc (ALC) 最新ニュース
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo Finance
Alcon Inc Stock Faces Patent Setback and Merger Termination: Key Implications for NYSE:ALC Investors - AD HOC NEWS
Volume Report: Is Alcon Inc benefiting from innovation trendsDay Trade & Verified High Yield Trade Plans - baoquankhu1.vn
Street Watch: Should I hold or sell Alcon Inc now2026 PreEarnings & Weekly Top Stock Performers List - baoquankhu1.vn
Sight Sciences wins $34M in Alcon patent case, ongoing royalty - Investing.com Australia
Alcon (ALC) Faces $34 Million Verdict in Patent Case - gurufocus.com
Alcon Fails to Undo $34 Million Patent Loss, Must Pay Royalties - Bloomberg Law News
Sight Sciences Wins $34 Million Patent Infringement Case Against Alcon, Secures Ongoing Royalties Through 2028 - minichart.com.sg
Sight Sciences Wins Infringement Lawsuit Against Alcon - National Today
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent - The Manila Times
Sight Sciences (NASDAQ: SGHT) awarded $34M plus 10% Hydrus royalties - Stock Titan
Sight Sciences Secures Order on Post-Trial Motions That - GlobeNewswire
Alcon Inc Stock: A Leader in Eye Care with Strong Growth Potential for North American Investors - AD HOC NEWS
Aug Drivers: Will Alcon Inc stock go up in YEARQuarterly Portfolio Report & Long-Term Safe Investment Ideas - baoquankhu1.vn
Lensar stock slumps after hours on ending merger deal with Alcon over FTC pushback - MSN
Alcon Inc Stock: Global Leader in Eye Care with Strong Growth Potential for North American Investors - AD HOC NEWS
Alcon announces $81 million expansion in Cabell County, 75 new jobs expected - WOWK 13 News
Alcon Inc Stock: Global Leader in Eye Care Innovation and Steady Growth Potential for Investors - AD HOC NEWS
Alcon Inc. Stock: A Leader in Eye Care Innovation Driving Steady Growth for North American Investors - AD HOC NEWS
ALC Stock Price, Quote & Chart | ALCON INC (NYSE:ALC) - ChartMill
Alcon expansion to create more West Virginia jobs - DC News Now
Alcon in Lesage to start making new vision product - WOWK 13 News
Systane Eye Drops: Alcon's Leading Solution for Dry Eye Relief in North America - AD HOC NEWS
Analyst Upgrade: Is Alcon Inc benefiting from innovation trendsPortfolio Update Report & Expert Verified Movement Alerts - baoquankhu1.vn
Alcon Inc stock faces uncertainty as Lensar merger collapses, pivots to organic growth strategy - AD HOC NEWS
LENSAR Inc stock plunges as Alcon terminates merger over FTC antitrust block - AD HOC NEWS
LENSAR Inc stock faces prolonged uncertainty as Alcon merger awaits FTC approval amid regulatory del - AD HOC NEWS
LENSAR Inc stock faces uncertainty as Alcon merger awaits final regulatory approval amid pending FTC - AD HOC NEWS
World Council of Optometry and Alcon Introduce Dry Eye Management Map - VisionMonday.com
Alcon Inc stock faces uncertainty as Lensar merger collapses, prompting strategic pivot to core eye - AD HOC NEWS
BTIG Reiterates 'Buy' Rating for Alcon (ALC) with $92 Price Targ - GuruFocus
Eaton Vance Worldwide Health Sciences Fund's Alcon Inc(XSWX:ALC) Holding History - GuruFocus
US LASIK Treatment Market Set to Witness Rapid Growth Through - openPR.com
Alcon Inc. stock faces steady demand amid eye care sector shifts and portfolio updates - ad-hoc-news.de
Is It Time To Reassess Alcon (SWX:ALC) After A 26.9% Share Price Slide? - Yahoo Finance
STAAR Surgical Co stock faces acquisition scrutiny as Alcon deal advances amid analyst caution - AD HOC NEWS
Guidance Update: Should I invest in Alcon Inc before earnings2026 Top Decliners & Comprehensive Market Scan Insights - baoquankhu1.vn
Alcon Inc stock faces pressure amid terminated LENSAR merger and market downturn - AD HOC NEWS
Alcon Inc. stock faces headwinds amid surgical slowdown and tariff risks in eye care sector - AD HOC NEWS
Alcon, LENSAR abandon proposed merger amidst FTC pushback - Ophthalmology Times
Alcon Inc. stock gains momentum as AlphaValue upgrades rating to Buy amid eye care sector resilience - AD HOC NEWS
Lensar agrees to terminate sale to Alcon - MSN
Systane Eye Drops Lead Alcon's Shift to Organic Growth After Lensar Deal Collapse - AD HOC NEWS
Alcon and Lensar terminate proposed merger after FTC pressure - Eyes On Eyecare
EV Market: Can Alcon Inc outperform in the next rally2026 Price Targets & Long-Term Growth Stock Strategies - baoquankhu1.vn
Alcon And LENSAR: Why The Broken Merger Creates Two Different Buy Cases (NYSE:ALC) - Seeking Alpha
Alcon and Lensar Agree to Terminate Merger Agreement - VisionMonday.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends - Investing.com Canada
ACQUISITIONS & MERGERS NEWS: FTC successfully blocks Alcon-LENSAR merger in cataract surgery laser market - VitalLaw.com
BTIG upgrades Lensar stock rating to buy after Alcon deal ends By Investing.com - Investing.com South Africa
Alcon Drops $430M Lensar Deal Under Pressure From FTC - Law360
Alcon Inc (ALC) 財務データ
収益
当期純利益
現金流量
EPS
0.83%
0.39%
大文字化:
|
ボリューム (24 時間):